Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,812,468
in 11 filings, $79.8M under 10b5-1 plans

Net −$79,812,468. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-10-03 Heerma Peter Chief Commercial Officer Sale −3,091 $8.25 $26K 80,257
2023-09-05 Cline Christopher R. Chief Financial Officer Sale −457 $14.71 $7K 50,574
2023-09-05 ROTE WILLIAM E. Senior Vice President, R&D Sale −1,815 $14.71 $27K 61,173
2023-09-05 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −1,815 $14.71 $27K 58,096
2023-09-05 Dube Eric M Chief Executive Officer Sale −4,455 $14.71 $66K 242,595
2023-08-31 ROTE WILLIAM E. Senior Vice President, R&D Grant or award +3,300 62,988
2023-08-31 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award +3,300 59,911
2023-08-31 Dube Eric M Chief Executive Officer Grant or award +9,900 247,050
2023-05-17 Baynes Roy D. Director Grant or award +4,500 24,500
2023-05-17 Baynes Roy D. Director Grant or award · Stock option (right to buy) +13,500 13,500
2023-05-17 Poole Sandra Director Grant or award +4,500 17,000
2023-05-17 Poole Sandra Director Grant or award · Stock option (right to buy) +13,500 13,500
2023-05-17 Williams Brinkley Ruth Director Grant or award +4,500 12,750
2023-05-17 Williams Brinkley Ruth Director Grant or award · Stock option (right to buy) +13,500 13,500
2023-05-17 Meckler Jeffrey A Director Grant or award +4,500 74,500
2023-05-17 Meckler Jeffrey A Director Grant or award · Stock option (right to buy) +13,500 13,500
2023-05-17 LYONS GARY A Director Grant or award +4,500 44,500
2023-05-17 LYONS GARY A Director Grant or award · Stock option (right to buy) +13,500 13,500
2023-05-17 COUGHLIN TIMOTHY Director Grant or award +4,500 42,500
2023-05-17 COUGHLIN TIMOTHY Director Grant or award · Stock option (right to buy) +13,500 13,500

Page 26 of 51 · 1,020 trades